NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome



Eyre, TA, Clifford, R, Bloor, A, Boyle, L, Roberts, C, Cabes, M, Collins, GP, Devereux, S, Follows, G, Fox, CP
et al (show 12 more authors) (2016) NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome. BRITISH JOURNAL OF HAEMATOLOGY, 175 (1). 43 - 54.

[img] Text
Eyre_et_al-2016-British_Journal_of_Haematology.pdf - Published Version

Download (470kB)
Item Type: Article
Uncontrolled Keywords: Ofatumumab, CHOP, TP53, Richter syndrome, Chronic lymphocytic leukaemia
Depositing User: Symplectic Admin
Date Deposited: 12 Sep 2018 08:34
Last Modified: 18 Jan 2021 20:13
DOI: 10.1111/bjh.14177
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3026122